| Discordance and conversion rates of progesterone-, estrogen-, and HER2/neu-receptor status in primary breast cancer and brain metastasis mainly triggered by hormone therapy M Timmer, JM Werner, G Roehn, M Ortmann, T Blau, C Cramer, ... Anticancer research 37 (9), 4859-4865, 2017 | 12 | 2017 |
| Combined amino acid positron emission tomography and advanced magnetic resonance imaging in glioma patients P Lohmann, JM Werner, NJ Shah, GR Fink, KJ Langen, N Galldiks Cancers 11 (2), 153, 2019 | 9 | 2019 |
| FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma P Lohmann, P Stavrinou, K Lipke, EK Bauer, G Ceccon, JM Werner, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-12, 2018 | 9 | 2018 |
| Dabrafenib treatment in a patient with an epithelioid glioblastoma and BRAF V600E mutation G Ceccon, JM Werner, V Dunkl, C Tscherpel, G Stoffels, A Brunn, ... International journal of molecular sciences 19 (4), 1090, 2018 | 8 | 2018 |
| Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI JM Werner, G Stoffels, T Lichtenstein, J Borggrefe, P Lohmann, G Ceccon, ... European journal of nuclear medicine and molecular imaging 46 (9), 1889-1901, 2019 | 3 | 2019 |
| Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma JM Werner, V Schweinsberg, M Schroeter, B von Reutern, MP Malter, ... Frontiers in Oncology 9, 84, 2019 | 3 | 2019 |
| Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and Pseudoprogression N Galldiks, M Kocher, G Ceccon, JM Werner, A Brunn, M Deckert, ... Neuro-oncology 22 (1), 17-30, 2020 | 2 | 2020 |
| Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI N Galldiks, JM Werner, C Tscherpel, GR Fink, KJ Langen Neuro-Oncology Advances 1 (1), vdz038, 2019 | 2 | 2019 |
| Expression of FAS-L differs from primary to relapsed low-grade gliomas and predicts progression-free survival JM Werner, S Kuhl, P Stavrinou, G Roehn, B Krischek, T Blau, ... Anticancer research 37 (12), 6639-6648, 2017 | 2 | 2017 |
| Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET EK Bauer, G Stoffels, T Blau, G Reifenberger, J Felsberg, JM Werner, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-10, 2020 | | 2020 |
| Flare phenomenon in O-(2-[18F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas CP Filss, AK Schmitz, G Stoffels, C Stegmayr, P Lohmann, JM Werner, ... Journal of Nuclear Medicine, jnumed. 119.238568, 2020 | | 2020 |
| Molecular imaging and advanced MRI findings following immunotherapy in patients with brain tumors N Galldiks, P Lohmann, JM Werner, G Ceccon, GR Fink, KJ Langen Expert Review of Anticancer Therapy, 2020 | | 2020 |
| NIMG-05. THE T2-FLAIR MISMATCH SIGN IN IDH-MUTANT ASTROCYTOMAS-IS THERE AN ASSOCIATION WITH FET PET UPTAKE? N Galldiks, JM Werner, G Stoffels, M Kocher, C Tscherpel, R Jain, N Shah, ... Neuro-Oncology 21 (Supplement_6), vi162-vi162, 2019 | | 2019 |
| NIMG-46. IMPACT OF FET PET ON MULTIDISCIPLINARY NEUROONCOLOGICAL TUMOR BOARD DECISIONS IN PATIENTS WITH BRAIN TUMORS G Ceccon, JM Werner, M Ruge, J Hampl, S Grau, R Goldbrunner, E Celik, ... Neuro-Oncology 21 (Supplement_6), vi171-vi172, 2019 | | 2019 |
| Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low-and High-Grade Gliomas JM Werner, S Kuhl, K Ulrich, B Krischek, P Stavrinou, R Goldbrunner, ... World neurosurgery 130, e17-e25, 2019 | | 2019 |
| Magnetic Resonance Imaging Reveals a Pronounced Treatment Response of a Isocitrate Dehydrogenase− and B-Raf Proto-Oncogene− Wildtype Epithelioid Glioblastoma JM Werner, A Brunn, GR Fink, N Galldiks World neurosurgery 127, 213-215, 2019 | | 2019 |
| Death Receptor 6 (DR6) Is Overexpressed in Astrocytomas S Stegmann, JM Werner, S Kuhl, G Roehn, B Krischek, P Stavrinou, ... Anticancer research 39 (5), 2299-2306, 2019 | | 2019 |
Gereon R. FinkProfessor of Neurology, University Hospital Cologne & Research Centre JülichDirección de correo verificada de fz-juelich.de
